Audentes Therapeutics (BOLD) Tops Q3 EPS by 47c
Tweet
Share
E-mail
Get Alerts BOLD Hot Sheet
Join SI Premium – FREE
Audentes Therapeutics (NASDAQ: BOLD) reported Q3 EPS of ($0.62), $0.47 better than the analyst estimate of ($1.09).
For earnings history and earnings-related data on Audentes Therapeutics (BOLD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ACCESS Newswire Inc. (ACCS) Misses Q2 EPS by 17c
- Zura Bio (ZURA) Misses Q2 EPS by 2c
- Craig-Hallum Reiterates Buy Rating on Plug Power (PLUG)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
